Ping Meng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
-
- RNA Research and Splicing 3
- Immunology 12
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Co-authors
- Lili Zhou (11 shared papers)Weijun Qin (6 shared papers)Fuli Wang (12 shared papers)Xiaoping Pan (1 shared paper)Feng Xiao (1 shared paper)Ren Lai (8 shared papers)Sumei Li (1 shared paper)Jianlin Yuan (3 shared papers)
- Journals
- Medicine (3 papers)Frontiers in Oncology (3 papers)Frontiers in Pharmacology (3 papers)Scientific Reports (2 papers)Andrology (2 papers)
- Partner nations
- ChinaGrenadaUnited States
In The Last Decade
Ping Meng
78 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 136
- Cancer Research 298
- Pharmaceutical Science 129
- Microbiology 74
- Molecular Biology 712
- Nephrology 59
Countries citing papers authored by Ping Meng
This map shows the geographic impact of Ping Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Meng more than expected).
Fields of papers citing papers by Ping Meng
This network shows the impact of papers produced by Ping Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Meng. The network helps show where Ping Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 201 | |
| 2 | 2021 | 125 | |
| 3 | 2009 | 125 | |
| 4 | 2015 | 104 | |
| 5 | 2015 | 83 | |
| 6 | 2020 | 48 | |
| 7 | 2017 | 46 | |
| 8 | 2019 | 45 | |
| 9 | 2018 | 45 | |
| 10 | 2009 | 42 | |
| 11 | 2013 | 38 | |
| 12 | 2022 | 33 | |
| 13 | 2018 | 31 | |
| 14 | 2014 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2019 | 28 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 23 | |
| 19 | 2022 | 23 | |
| 20 | 2022 | 20 |
About Ping Meng
Ping Meng is a scholar working on Molecular Biology, Immunology, Genetics, Nephrology and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Sexual function and dysfunction studies (6 papers), RNA Research and Splicing (3 papers), Prostate Cancer Treatment and Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Zebrafish Biomedical Research Applications (3 papers), Renal cell carcinoma treatment (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Cancer Research (298 citations), Pharmaceutical Science (129 citations), Microbiology (74 citations), Molecular Biology (712 citations) and Nephrology (59 citations). Ping Meng has collaborated with scholars based in China, Grenada and United States. Frequent co-authors include Lili Zhou, Weijun Qin, Fuli Wang, Xiaoping Pan, Feng Xiao, Ren Lai, Sumei Li, Jianlin Yuan, Yunfang Zhang and Mingqiang Rong. Their work appears in journals such as Medicine, Frontiers in Oncology, Frontiers in Pharmacology, Scientific Reports and Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.